A Randomized, Single-blind, Parallel Group and Multiple - Dose Design Study

Clinical trial NCT03451487 · COMPLETED

Trial details

NCT number: NCT03451487
Sponsor: Sinew Pharma Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Acetaminophen Toxicity

Start date: 2022-05-19
Primary completion: 2022-12-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.